Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
Fuji
Boehringer Ingelheim
Baxter
Queensland Health
Johnson and Johnson

Generated: September 19, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for LGX818

  Try a free trial


See Plans and Pricing

« Back to Dashboard

US Patents for LGX818

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
LGX818 ➤ Sign Up Compounds and compositions as protein kinase inhibitors Array BioPharma Inc. (Boulder, CO) ➤ Sign Up
LGX818 ➤ Sign Up Method of treating colorectal cancer by administration of pharmaceutical formulations of (S)-methyl (1-((4-(3-(5-chloro-2-fluoro-3-(methylsulfonamido)pheny1)-1-isopropyl-1H-- pyrazol-4-yl)pyrimidin-2-yl)amino)propan-2-yl) carbamate Array BioPharma Inc. (Boulder, CO) ➤ Sign Up
LGX818 ➤ Sign Up Compounds and compositions as protein kinase inhibitors IRM LLC (Hamilton, BM) Novartis AG (Basel, CH) ➤ Sign Up
LGX818 ➤ Sign Up 3,4-diarylpyrazoles as protein kinase inhibitors Nerviano Medical Sciences S.R.L. (Nerviano, IT) ➤ Sign Up
LGX818 ➤ Sign Up 3,4-diarylpyrazoles as protein kinase inhibitors Nerviano Medical Sciences S.R.L. (Nerviano (MI), IT) ➤ Sign Up
LGX818 ➤ Sign Up Compounds and compositions as protein kinase inhibitors Novartis AG (Basel, CH) ➤ Sign Up
LGX818 ➤ Sign Up Pharmaceutical formulations of (S)-methyl (1-((4-(3-(5-chloro-2-fluoro-3-(methylsulfonamido)phenyl)-1-isopropyl-1H-- pyrazol-4-yl)pyrimidin-2-yl)amino)propan-2-yl)carbamate Novartis AG (Basel, CH) ➤ Sign Up
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

Subscribe to access the full database, or try a Free Trial

International Patents for LGX818

Drugname Country Document Number Estimated Expiration Related US Patent
LGX818 Argentina 077975 2029-08-28 ➤ Sign Up
LGX818 Australia 2010286569 2029-08-28 ➤ Sign Up
LGX818 Canada 2771775 2029-08-28 ➤ Sign Up
LGX818 China 102725283 2029-08-28 ➤ Sign Up
LGX818 China 103896921 2029-08-28 ➤ Sign Up
LGX818 Colombia 6612222 2029-08-28 ➤ Sign Up
LGX818 Costa Rica 20120102 2029-08-28 ➤ Sign Up
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Army
Argus Health
Teva
Citi
Deloitte
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.